Analyst Price Targets — ACET
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 6, 2026 11:23 am | — | Canaccord Genuity | $18.00 | $8.15 | TheFly | Adicet Bio price target lowered to $18 from $128 at Canaccord |
| December 12, 2022 6:19 am | — | H.C. Wainwright | $608.00 | $276.32 | Benzinga | HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $38 |
| March 4, 2022 12:00 am | Kelly Shi | Jefferies | $432.00 | $200.96 | Pulse 2.0 | Adicet Bio (ACET) Stock: Why The Price Increased Today |
Latest News for ACET
Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
Adicet Bio NASDAQ: ACET outlined its near-term clinical priorities and upcoming data catalysts during a fireside chat at the Jefferies Healthcare Conference in New York, with President and CEO Chen Schor emphasizing the company's focus on off-the-shelf gamma delta 1 T-cell therapies for autoimmune disease and oncology.
Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
The average of price targets set by Wall Street analysts indicates a potential upside of 319.6% in Adicet Bio (ACET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial results and operational highlights for the first quarter ended March 31, 2026. “Adicet is approaching a key inflection point as we prepare to report Phase 1 data for prula-cel in…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACET.
U.S. House Trading
No House trades found for ACET.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.